New Pathology Partnership to Transform Patient Care in UK Capital
A partnership that will transform pathology services and help to improve the quality of patient care across South East London has today gone live. Over…
Category:
News
SYNLAB partners with Bristol Airport to provide first class COVID-19 testing service
SYNLAB is teaming up with Bristol Airport to provide its customers with access to a high quality COVID-19 testing service which could reduce the time…
Pathology First Quality Team
A Day in the Life of the Pathology First Quality Team: Kim Aston Quality Manager and Katie Stewart-Byrne Did you know both Katie and Kim…
MP praises Southwest Pathology Service’s role in the fight against COVID-19
The Southwest Pathology Service (SPS) – which has been at the forefront of the national effort to provide potentially life-saving COVID-19 testing – has been…
Press Statement: SYNLAB UK & Ireland Announced As Partner In Major Pathology Partnership Contract
We are delighted to announce that SYNLAB UK & Ireland will become the new pathology partner to Guy’s and St Thomas’ NHS Foundation Trust and…
SYNLAB Laboratory Services Maintains ISO 15189:2012 UKAS Accreditation
SYNLAB Laboratory Services, part of Europe’s leading medical diagnostics provider SYNLAB Group, is pleased to announce that the company has successfully maintained its UKAS ISO…
Press Statement: SYNLAB UK & Ireland Confirmed as Preferred NHS Strategic Partner
SYNLAB UK & Ireland has been confirmed as the preferred strategic partner to transform and deliver NHS pathology services in South East London. SYNLAB UK & Ireland’s…
Pathology First shortlisted as a finalist for the HSJ Partnership Awards 2020
SYNLAB UK & Ireland is delighted to announce Pathology First has been shortlisted as a finalist in the category of Best Healthcare Provider Partnership with…
SYNLAB launch Faecal Immunochemical Testing (FIT)
SYNLAB have announced the launch of Faecal Immunochemical Testing (FIT), a bowel / colorectal cancer screening test. FIT is a more sensitive screening test which…
Leukaemia patient goes behind the scenes at The Christie Pathology Partnership
As part of National Biomedical Science Day, the Christie Pathology Partnership (CPP), based at The Christie in Manchester, opened its doors and gave a special…
The Christie Pathology Partnership Begins Offering VENTANA PD-L1 (SP142) Assay as Companion Diagnostic Test in Bladder Cancer Patients
Following NICE approval in December 2018 a companion diagnostic test is required to determine PD-L1 levels in the tumour tissue of cisplatin-ineligible patients with locally…
Healthcare Science Week – what’s it like being a Biomedical Scientist (BMS) at Europe’s largest cancer centre?
Jamie Wild is a Biomedical Scientist (BMS) at the Christie Pathology Partnership (CPP), one of the UK’s leading reference centres specialising in cancer detection and…